Target Protein Degradation Market is projected to be over USD 3

• Posted by Stella Wilson May 12, 2021 - Filed in Health - #Target Protein Degradation Market  - 1,022 views

  The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago.

  Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to soon enter the market.

  The USD 3.6 billion (by 2030) financial opportunity within the Target Protein Degradation Market has been analyzed across the following segments:

  Type of payment of licensing agreements

  • Upfront payments
  • Milestone payments

  Type of protein degrader

  • Degronimids
  • PROTACs
  • SARDs / SERDs
  • Specific BET and DUB inhibitors
  • Other protein degraders

  Therapeutic area

  • Neurodegenerative disorders
  • Oncological disorders
  • Other therapeutic areas

  Route of administration 

  • Oral
  • Intravenous
  • Other routes

  Key geographical region

  • North America
  • Europe
  • Asia-Pacific

  The Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030 report features the following companies, which we identified to be key players in this domain:

  Get detailed Analysis:

  https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html

  Key Players

  • Arvinas
  • Captor Therapeutics
  • Celgene
  • Genetech
  • Kymera Therapeutics
  • Mission Therapeutics
  • Progenra
  • Radius Health
  • Sanofi Genzyme
  • Zenopharm

  Table of Contents

  1. Preface
  2. Executive Summary
  3. Introduction
  4. Current Market Landscape
  5. Company Profiles
  6. Clinical Trial Analysis
  7. KOL Analysis
  8. Publication Analysis
  9. Funding and Investment Analysis
  10. Partnerships and Collaborations
  11. Market Sizing and Opportunity Analysis
  12. Executive Insights
  13. Concluding Remarks
  14. Appendix 1: Tabulated Data
  15. Appendix 2: List of Companies and Organizations

  Get Customized Report: https://www.rootsanalysis.com/reports/289/request-customization.html

  About Roots Analysis

  Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.

  Contact Information

  Roots Analysis Private Limited

  Gaurav Chaudhary

  +1 (415) 800 3415

  Gaurav.Chaudhary@rootsanalysis.com

   

  Also Visit Our Latest Publication:

  Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market

  CAR-T Cell Therapies Market

  Patient Recruitment and Retention Services Market

  mRNA Therapeutics and Vaccines Market

  T-Cell (CAR-T, TCR, and TIL) Therapies Market